Palvella Therapeutics, Inc. (PVLA)

NASDAQ

$124.96

$-0.86

(-0.68%)

Previous Close: ⁦$126.39⁩

Market Closed

Palvella Therapeutics, Inc. (PVLA) Live Price Chart

Last updated: ⁦2026-10-24 08:11:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Palvella Therapeutics, Inc. (PVLA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $124.96, with a market capitalization of $1.82B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $68.96 to $161.38. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.82B
Open	$124.60
Day's High	$161.38
Day's Low	$11.17
Previous Close	$126.39
Volume	133.97K
Average Volume	207.49K
P/E Ratio	--
52-Week High	$161.38
52-Week Low	$68.96
Dividend Yield	--
Earnings Date	--

Palvella Therapeutics, Inc. (PVLA) Latest Closing Stock Price

Palvella Therapeutics, Inc. (PVLA) last closed at $126.39 as of 2026-10-23 23:31:00, unchanged from the previous close of $126.39.

During the latest regular trading session, PVLA traded between $11.17 and $161.38, with a volume of 133.97K shares. The closing price was near the upper end and near the middle of its 52-week range.

Palvella Therapeutics, Inc. (PVLA) 7-Day Stock Price Change

Over the past seven days, Palvella Therapeutics, Inc. (PVLA) moved from $127.34 to $124.96, representing a decline of 1.87% ($2.38).

The stock traded between $118.23 and $131.03 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 212.47 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

PVLA 52-Week Price Position

Position in Range: 60.6%

52W Low$68.96

52W High$161.38

PVLA is currently trading at $124.96, placing it 60.6% of the way from its 52-week low of $68.96 to its 52-week high of $161.38. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Palvella Therapeutics, Inc. (PVLA)?

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.

Palvella Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	29
Exchange	NASDAQ
Company Website	https://www.palvellatx.com

How to Buy Palvella Therapeutics, Inc. (PVLA) Stock on MEXC

Eligible investors can buy real shares of Palvella Therapeutics, Inc. (PVLA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PVLA and Place Your Order

Open the RealStocks trading page and search for PVLA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Palvella Therapeutics, Inc. (PVLA) stock price today?

Palvella Therapeutics, Inc. (PVLA) is currently trading at $ 124.96, down 1.13% ($1.43) from the previous close of $ 126.39. Intraday prices update in real time during regular trading hours.

2.Is PVLA stock going up or down today?

As of 2026-10-23 23:31:00, PVLA is trading at $ 124.96, down 1.13% ($1.43) from its previous close of $ 126.39. The stock has traded between $ 11.17 and $ 161.38 during today’s regular session. Past price movements do not guarantee future results.

3.What is PVLA pre-market price?

As of 2026-10-23 23:31:00, PVLA is trading at $ 125.93 in pre-market trading, down 0.36% ($0.46) from the previous close of $ 126.39. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PVLA after-hours price?

As of 2026-10-23 23:31:00, PVLA is trading at $ 125.20 in after-hours trading, down 0.95% ($1.20) from the regular-session close of $ 126.39. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is PVLA stock trading now?

PVLA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PVLA sit relative to its 52-week high and low?

Over the past 52 weeks, PVLA has traded between a low of $ 68.96 and a high of $ 161.38. At $ 124.96, the stock is positioned 60.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Palvella Therapeutics, Inc. in?

Palvella Therapeutics, Inc. (PVLA) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Palvella Therapeutics, Inc.'s market capitalization and where is it listed?

Palvella Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 1.82B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PVLA valued in terms of P/E ratio and EPS?

PVLA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -4.28. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Palvella Therapeutics, Inc. pay a dividend?

Palvella Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.